AVGO closed at $329.17 on October 26, 2026, up 2.33% from $321.68 on 18.49 million shares - 0.86x the 21.53 million 20-day average and 0.82x the 22.54 million 60-day average - with the session ranging $323.30 to $332.12 and settling at 66.6% of that range, the first constructive intraday shape since the October 21 bounce. The macro tape improved: fell 5.45% to 18.39, the 10-year held at 4.986%, the S&P 500 rose 0.70%, the Nasdaq gained 0.82%, and AVGO outperformed the Nasdaq by about 150 basis points, a sharp reversal from October 23 when it lagged a relatively stronger tech tape. The bounce is real but incomplete: price remains 5.33% below the $347.69 , 7.51% below the $355.89 and 9.12% below the $362.20 , and the / death-cross gap widened for an eighth consecutive session to -$6.31 from -$5.55. Momentum improved at the margin - histogram contracted to -2.479 from -2.999, rose to 39.65 from 34.26, and jumped by the full session volume to -18.12 million - but the line made a lower low at -9.008 and price has not reclaimed the $334.61 shelf or the $347.69 . The fundamental franchise remains elite and is cheaper after the drawdown: 75.52% gross margin, 54.31% operating margin, 44.24% , $40.65 billion operating cash flow converting to $30.60 billion free cash flow, 85.5% revenue growth and 215.3% earnings growth, all at 42.04x trailing and 16.94x forward earnings on the $19.4315 next-year consensus with a 0.3185 . The forward curve has finally stopped falling: next-year rose to $19.4315 from $19.39695 seven days ago and $19.3807 thirty days ago, the seven-day revision count shows zero downgrades across all four buckets, and current-year of $11.65924 is the highest in the observed series with 22 upward versus 15 downward revisions over 30 days. Sell-side posture remains heavily long-biased - 48 of 51 ratings are Buy or better, the mean target is $529.10 (60.7% above spot), and Tigress Financial initiated at Buy with a $600 target on October 22 - but the mean target has barely moved while the stock bounced, so the gap reflects stale models rather than a near-term floor. The news flow is stale: all five supplied articles are dated September 30, 2026, now 26 days old, and the only AVGO-specific item is Netlist's ITC complaint over two high-bandwidth-memory patents seeking exclusion and cease-and-desist orders against Micron and named downstream customers including certain Broadcom products; it is an allegation without an infringement finding or shipment disruption. The next scheduled catalyst is the December 9 fiscal Q4 report, 43 days away, which is outside the one-month window but is the first hard checkpoint on custom-AI shipments and the $19.4315 next-year estimate. The key risk is that October 26 was an oversold bounce on light volume rather than a trend reversal: volume was only 0.86x average, is still negative, the lower-highs sequence from the $380.84 October 6 peak is intact, and the 10-year at 4.986% still caps a 42x trailing multiple with a 1.95% FCF yield below the risk-free rate. A 10% cut to the $19.4315 next-year estimate at 16.94x implies about $296, and a 15x de-rating on the unchanged estimate implies about $291, both roughly 10-12% below spot and essentially the $289.96 52-week low. Net: HOLD overall and for the next month, HOLD at six months, and BUY at one year only on a basis that starts lower or on a confirmed reclaim of $347.69; the franchise is intact, but the chart has not repaired.
Decision
Live price
$342.73
Recommendation score
46%
46%
Confidence
68%
68%
Outlook by horizon
1M
HOLD
Near
6M
HOLD
Mid
1Y
BUY
Long
Primary catalyst
The December 9, 2026 fiscal Q4 report, now 43 days out, is the highest-impact scheduled item: it is the first hard checkpoint on custom-AI shipments and the $19.4315 next-year estimate, and it is the only AVGO-specific fundamental catalyst inside the next two months. The nearest unscheduled risk is the Netlist ITC complaint over two high-bandwidth-memory patents, which could produce a headline gap at any time; no infringement finding, shipment disruption, or reflected cost exists in any current estimate, but the proceeding is binary.
The October 26 +2.33% bounce on 0.86x average volume improves the tactical tone but does not repair the trend: price is still 5.33%, 7.51% and 9.12% below the , and , and the / gap widened for an eighth consecutive session to -$6.31. Keep core exposure but do not chase; tactical longs should be no more than 50% of normal size, entered on a pullback to $320-$325 or on a daily close above $347.69 with volume above 21.53 million. A 3.40% and 38.53% realized volatility mean a two- stop is roughly $22.40 wide, so risk must be controlled through size rather than through tight stops. Trim into $348-$360 if the bounce stalls.
Thesis Snapshot
Why It Works
The bull case is that October 26 was the first genuine accumulation day in weeks: AVGO rose 2.33% to $329.17, closed at 66.6% of the session range, outperformed the Nasdaq by about 150 basis points, and rose by the full 18.49 million shares traded, erasing the October 23 decline. The fundamental franchise is elite and cheaper: 75.52% gross margin, 54.31% operating margin, 44.24% , $40.65 billion of operating cash flow converting to $30.60 billion of free cash flow, 85.5% revenue growth, 215.3% earnings growth, 16.94x forward earnings and a 0.3185 . The forward curve has inflected: next-year rose to $19.4315 from $19.3807 a month ago, the seven-day revision count shows zero downgrades across all four buckets, current-year of $11.65924 is the highest in the observed series, and 48 of 51 ratings are Buy or better with a $529.10 mean target 60.7% above spot. The bear math is also limited: a 10% cut to next-year at 16.94x implies about $296, and a 15x de-rating on the unchanged estimate implies about $291, both only 10%-12% below spot and essentially on the $289.96 52-week low. Tracking the prior plan honestly: the $298-$315 entry zone was never reached (the low since is $320.23 on October 23); the $340-$352 exit zone was not reached (the high since is $332.12 on October 26); the $285 stop was not hit; the $289.96 invalidation level was not triggered; and the prior one-month SELL call was wrong over the latest session, with AVGO up 2.33% since the last analysis.
What Breaks It
The honest bear case is that October 26 was a one-day oversold bounce on light volume, not a trend reversal. Price is still below all three moving averages, the / death-cross gap widened for an eighth straight session to -$6.31, the lower-highs sequence from the $380.84 October 6 peak is intact, and the October 21 reclaim of $334.61 remains three sessions rejected. The line made a lower low at -9.008, at 39.65 is still below 40 and well below 50, and at -18.12 million is still negative and below the October 21 level of +7.40 million. The bounce came on 0.86x the 20-day average volume, so it lacks conviction; capitulation days in this series clustered at 28-30 million shares and no such low was printed. The 10-year at 4.986% still caps a 42.04x trailing multiple, the 1.95% FCF yield is below the risk-free rate, next-year at $19.4315 remains below its 60-day ($19.55167) and 90-day ($19.58228) marks with 26 down versus 13 up revisions over 30 days, the Netlist ITC complaint is unquantified and unscheduled, and all news is 26 days stale. A failure at $332-$347 would resume the measured move toward $288-$290. The prior one-month SELL call was wrong for one session, but the primary trend is still down.
A daily close below $289.96, the 52-week low, which is also where the measured move from the $380.84 October 6 high through the broken $334.61 shelf projects at roughly $288, would mean the entire 2026 AI-driven re-rating has unwound and the value case is refuted rather than merely early; exit the position rather than sizing into it. The symmetric upside repair signal is a daily close above the $347.69 on volume above 21.53 million accompanied by continued upward drift in the $19.4315 next-year estimate, which would invalidate the bearish near-term posture and argue for rebuilding exposure.
Rate and valuation risk: 42.04x trailing earnings, 17.63x sales, 15.76x book, 30.06x and a 1.95% FCF yield, with the 10-year at 4.986%; a 10% cut to the $19.4315 next-year estimate at 16.94x implies about $296, and a de-rating to 15x on the unchanged estimate implies about $291, both roughly 10%-12% below $329.17 and essentially on the $289.96 52-week low.
Estimate and execution risk: current-quarter carries 24 downward versus 9 upward revisions over 30 days and next-year 26 versus 13; current-quarter of $3.83018 already sits below its 60-day ($3.87825) and 90-day ($3.86088) marks, and a delay in custom-silicon qualification or hyperscaler deployment could reverse the two-reading uptick in the $19.4315 next-year number, leaving the December 9 report 43 days out as a binary event.
Legal and HBM supply-chain risk: the unresolved Netlist ITC complaint seeks exclusion and cease-and-desist orders over two high-bandwidth-memory patents against Micron and named downstream customers including certain Broadcom products; no infringement finding or shipment disruption is reported, so timing is binary and the dollar exposure is unquantified and absent from every current analyst estimate.
Balance sheet and customer concentration: $35.44 billion of net debt with cash covering only 0.40x gross debt and operating cash flow covering gross debt just 0.68x, alongside a semiconductor franchise concentrated in a handful of hyperscaler customers; two supplied articles explicitly question what happens to Broadcom's pricing power and cash generation if AI infrastructure spending or customer concentration shifts, and the prior analysis flagged a customer-compute SPV with partial Broadcom guarantees whose current terms are unavailable, so contingent exposure cannot be sized.
Momentum, positioning and data-staleness risk: price is below all three moving averages with the death-cross gap at -$6.31 and widening, at -9.008, and at -18.12 million; simultaneously is 18.39 and the 10-year is 4.986%, a combination a 1.476-beta, 38.53%-volatility name is unlikely to escape if broad de-risking continues. Every supplied news item is dated September 30, 2026 (26 days stale), all Bollinger Band fields are null, the insider feed carries malformed dates and blank transaction types and lost a record versus the prior run, and the analyst-count field is null, so the narrative cannot capture developments between September 30 and October 26.
Watch Next
Next earnings: Dec 9, 2026
The December 9, 2026 fiscal Q4 report, now 43 days out, is the highest-impact scheduled item: it is the first hard checkpoint on custom-AI shipments and the $19.4315 next-year estimate, and it is the only AVGO-specific fundamental catalyst inside the next two months. The nearest unscheduled risk is the Netlist ITC complaint over two high-bandwidth-memory patents, which could produce a headline gap at any time; no infringement finding, shipment disruption, or reflected cost exists in any current estimate, but the proceeding is binary.
Signal Dashboard
Decision inputs
6 signals
Fundamental
60.7%
Upside to analyst mean target
At $329.17, AVGO trades at 42.04x trailing earnings and 16.94x forward earnings on the $19.4315 next-year consensus, against 17.63x sales, 15.76x book, 30.06x and a 1.95% free-cash-flow yield on a $1.571 trillion market cap. The forward multiple is genuinely undemanding for a business compounding revenue at 85.5% year over year and earnings at 215.3%, and the supplied of 0.3185 is far inside the 1.5x threshold that normally marks attractive growth-adjusted value. The absolute stack remains demanding, however, because 17.63x sales and a 1.95% cash yield are being measured against a 4.986% risk-free rate, and the shares are still 33.5% below the $495.00 52-week high. The sensitivity is precise: a 10% cut to the $19.4315 next-year estimate at a constant 16.94x multiple implies approximately $296, while a de-rating to 15x on the unchanged estimate implies approximately $291 - both distress paths converge roughly 10%-12% below spot and essentially on the $289.96 52-week low. Upside references are far wider: the $529.10 mean target is 60.7% above spot, the $537.50 median is 63.3% above, the $660.00 high is 100.5% above and the $215.88 low is 34.4% below, a high-to-low ratio of 3.06x. No same-date peer or historical valuation series is supplied, so a relative discount or premium to semiconductor peers cannot be substantiated from this bundle. Net: attractive on forward earnings and , expensive on sales, book and current cash yield, with a de-rating that has already surrendered roughly 81% of the 52-week range without yet confirming a floor.
Technical
Neutral
Trend quality
At $329.17 the shares sit 5.33% below the $347.69 , 7.51% below the $355.89 , and 9.12% below the $362.20 - below all three reference averages, although the October 26 session closed above the October 23 high of $327.70 and above the October 22 close of $323.24. The / relationship continues to deteriorate: at $355.89 sits $6.31 below at $362.20, versus a $5.55 gap on October 23, $4.52 on October 22, $3.48 on October 21, $2.84 on October 20, $2.05 on October 19, $1.23 on October 16 and just $0.19 on October 15, so the death cross has widened for an eighth consecutive session even as both averages roll lower. The sequence of lower highs from the October 6 peak of $380.84 remains technically unbroken, and the October 21 close of $337.80 back above the $334.61 shelf is now three full sessions rejected, with October 22 gapping down to $323.24, October 23 failing at $321.68, and October 26 only reaching $332.12 intraday before closing at $329.17. The stock is 33.5% below the $495.00 52-week high and only 13.52% above the $289.96 52-week low with a 52-week range position of just 19.12%, so the base-building hypothesis is not confirmed and the pattern is still a downtrend with the measured move from the $380.84 high through the $334.61 break projecting to roughly $288, essentially the 52-week low, as the operative downside target. The one constructive nuance is that the has rolled down from $350.27 to $347.69 and from $358.43 to $355.89, so the bar for a trend-repair reclaim is falling roughly a dollar a session.
Earnings
43d
Accelerating
Fiscal Q3 2026 (quarter ended July 31, 2026) reported of $3.32 versus $3.238 consensus, a 2.53% beat and the sixth consecutive supplied beat; realized has risen every quarter from $1.58 to $3.32, roughly 96.4% year over year in the latest period and 36.1% sequentially off the $2.44 April 2026 quarter. Caveats: the bundle contains no release-day price reaction and no company guidance record, all five supplied news items are dated September 30 (now 26 days stale), and the realized acceleration is only now being mirrored by forward revisions - next-year of $19.4315 still sits below its 60-day ($19.55167) and 90-day ($19.58228) marks, but it has risen for two consecutive readings from $19.3807 thirty days ago, with zero seven-day downgrades across all four buckets. The realized series is accelerating and the forward estimate curve has stopped falling, but the burden of proof still rests on the December 9 report, 43 days out.
News
Mixed-Bullish
Headline tone
The December 9, 2026 fiscal Q4 report, now 43 days out, is the highest-impact scheduled item: it is the first hard checkpoint on custom-AI shipments and the $19.4315 next-year estimate, and it is the only AVGO-specific fundamental catalyst inside the next two months. The nearest unscheduled risk is the Netlist ITC complaint over two high-bandwidth-memory patents, which could produce a headline gap at any time; no infringement finding, shipment disruption, or reflected cost exists in any current estimate, but the proceeding is binary.
Macro
Neutral
4.99% 10Y / 18.4 VIX
fell 5.45% to 18.39 and the 10-year held at 4.986%, so the immediate pressure on high-multiple growth eased and the Nasdaq's 0.82% gain supported AVGO's 2.33% bounce; however, with still above 15 and the 10-year near 5%, a 42.04x trailing multiple and 1.476 beta remain vulnerable to any renewed yield spike.
Stability
High-Beta Growth
Satellite Upside
Broadcom remains a high-beta growth asset rather than a core anchor: beta is 1.476, 20-day realized volatility is 38.53%, (14) is $11.198 or 3.40% of the $329.17 close, and the shares sit 33.5% below the $495.00 52-week high with a 52-week range position of only 19.12% and just 13.52% of cushion above the $289.96 low. The October 26 +2.33% bounce on 0.86x average volume improves the tactical tone but does not change the risk character: the stock has repeatedly lost 4%+ in a single session while the franchise executed. Business quality is genuinely elite - 75.52% gross margin, 54.31% operating margin, 44.24% , $40.65 billion of operating cash flow converting to $30.60 billion of free cash flow - which is why thesis durability stays High and the name belongs in a growth sleeve rather than a pure tactical-trade bucket. It is not a Defensive or Stable Compounder because 42.04x trailing earnings and 17.63x sales remain acutely rate-sensitive with the 10-year at 4.986%, net debt is $35.44 billion, and the AI growth vector depends on a concentrated set of hyperscaler capex schedules that can be deferred by a quarter without warning. Size it as Satellite Upside at partial weight and underwrite 30-40% peak-to-trough drawdowns rather than treating it as a core compounding position.
Analyst Spread
Mean Target
$529.10
High / Low
$216 / $660
Median Target
$537.50
Consensus range
$216 - $660
— analysts
Mean
$216$529$660
Consensus
The $529.10 mean target implies roughly 60.7% upside from $329.17 and the $537.50 median implies about 63.3%. The $215.88 low target implies about 34.4% downside and the $660.00 high implies about 100.5% upside, a high-to-low ratio of 3.06x - very wide, indicating genuine disagreement about the durability and timing of the AI capex cycle rather than mere noise. The analyst-count field is null, but the recommendation panel contains 51 ratings with 48 of them Buy or Strong Buy, 3 Hold and zero Sell, so sell-side positioning is heavily long-biased; the panel is slightly firmer than one month ago (7 Strong Buy / 40 Buy / 3 Hold) and firmer than the -2m mark of 8/37/4. The mean target has barely moved while the stock bounced 2.33% on October 26, which means the 60.7% implied gap is a statement about stale sell-side models rather than about near-term price direction - a consensus this one-sided is a sentiment support, not a price floor, and with short interest at only 1.16% of float the crowded side of the boat is the long side. Note also that the bundle's analyst_price_targets.current_price_target field carries $329.17, identical to the spot price, so it is a pipeline artifact rather than a genuine current target and should be ignored.
Positioning Pulse
Insider Signal
Neutral
Net Bias
No recent activity
Insider Own.
1.9%
Institutional Own.
79.7%
Interpretation
Because the feed does not distinguish buys from sells, carries no usable dates or 10b5-1 plan designations, and implies share prices far below both the current and September marks, it provides no reliable evidence of insider conviction or distribution; insider activity should be treated as a non-signal this cycle rather than as confirmation of either the bullish sell-side consensus or the still-bearish trend structure.
Notable activity
The feed lists only two records: CEO Hock E. Tan with 45,000 direct shares valued at about $10.80 million and director Diane M. Bryant with 15,000 direct shares worth about $3.40 million. Transaction types are blank and the date fields are malformed placeholders ('98', '99'), and the implied per-share prices work out to roughly $239.96 for Tan and $226.68 for Bryant - 27% to 31% below the current $329.17 close and well below both the $355.60 reference price in the September 30 news item and the $415.73 GF Value cited there. That internal inconsistency, combined with the feed having dropped the Brazeal record present in the prior run, confirms the data is stale or mis-dated rather than evidence of current-period distribution or accumulation.
Market Context
Industry
Semiconductors
Mixed-Bullish
Sentiment
31
Tracked names
13
Grouping
industry
Semiconductors industry is currently Mixed-Bullish with an average recommendation score near 55. capital and conviction are improving across the group, and leadership is concentrated in NVDA, TSM, MU.
Rotation Drivers
Average recommendation deltas are trending higher across Semiconductors industry, which suggests improving risk appetite inside the group.
3 names are rated bullish versus 0 bearish names, keeping the group tone mixed-bullish.
Leadership is concentrated in NVDA, TSM, MU, so those names are the cleanest read on group-level capital rotation.
Custom silicon, high-speed networking and data movement remain the most durable structural expression of AI data-center investment, and Broadcom pairs those semiconductor exposures with a roughly $29.7 billion infrastructure-software business that generates recurring cash against $59.4 billion of semiconductor revenue. The end-demand evidence is still constructive - HPE raised its long-term networking growth forecast, announced a $1.2 billion Vultr deal and rose 3.9%, and the GDP revision to 2.2% explicitly credited AI-infrastructure investment. But the theme is only now stabilizing at the leader's share price: AVGO is 6.7% lower over one month and 2.8% lower year to date, sits 9.12% below its , yet rallied 2.33% on October 26 versus the Nasdaq's 0.82% and printed the first meaningful accumulation day since October 7. The market is discriminating between AI capex that is contracted and AI multiples that were priced for perfection, and the offset in this run is that the estimate curve behind the theme has stopped falling - next-year ticked up to $19.4315 from $19.3807 a month ago.
AVGO's October 26 relative strength and the first accumulation day since October 7, combined with zero seven-day estimate downgrades across all four buckets, mark the first evidence that the AI-infrastructure theme is stabilizing at the stock level ahead of the December 9 print.
HPE raised its long-term networking revenue growth forecast and announced a $1.2 billion Vultr AI-infrastructure deal, an adjacent confirmation that data-center networking spend is still expanding even as AVGO's multiple compresses.
Second-quarter GDP was revised higher to a 2.2% annualized rate with AI-infrastructure investment cited as a driver, so the capex cycle behind the theme is still funded; the constraint on AVGO is valuation, positioning and estimate direction, not end demand.
AVGO's custom AI networking silicon and data-movement chips plug directly into the largest data-center buildouts, while the roughly $29.7 billion software arm adds a recurring cash engine that can smooth hardware cycles.
Long-Duration Growth De-Rating Under A ~5% 10-Year
Score: -18
Mixed-Bearish
The defining tension of this cycle remains the discount rate: the 10-year held at 4.986% on October 26, still near 5% and near multi-decade highs, even as fell 5.45% to 18.39 and the Nasdaq rose 0.82%. For AVGO this is doubly punitive - 42.04x trailing earnings, 17.63x sales and 30.06x get no help when yields are near 5%, and the 1.95% free-cash-flow yield is less than half the 4.986% risk-free alternative, which caps how much value support the de-rating can generate on its own. The October 26 bounce is a relief rally within a de-rating, not a resolution: the stock is still 33.5% below its 52-week high and 9.12% below its , and the next test is whether the 10-year stays below 5% through the December 9 earnings.
down to 18.39 and the 10-year stable at 4.986% gave high-multiple growth a one-day reprieve; the test is whether yields stay below 5% through the December 9 print, because a renewed move toward 5.25%-5.50% would mechanically compress AVGO's 42x trailing multiple.
fell 5.45% to 18.39, moving away from the 20 level that forces volatility-targeted and risk-parity capital to reduce exposure to high-beta names.
The 10-year held at 4.986% rather than extending its prior move, providing temporary relief for long-duration growth multiples.
The Nasdaq rose 0.82% and AVGO rose 2.33%, showing that technology leadership can reassert when yields stabilize; however, the 1.95% FCF yield remains below the risk-free rate, so the structural de-rating pressure is not resolved.
Key Stats
23 metrics total
Market Cap
$1.57T
P/E (TTM)
42.0
Forward P/E
16.9
Revenue Growth
85.5%
ROE
44.2%
Beta
1.48
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
17.6
Price / Book
15.8
EV / EBITDA
30.1
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
75.5%
Operating Margin
54.3%
Debt / Equity
59.6
Current Ratio
2.50x
Quick Ratio
2.15x
Positioning & Range
Short interest and 52-week location.
Short % Float
1.2%
Short Ratio
2.01x
52W High
$495.00
52W Low
$289.96
From 52W High
-33.5%
From 52W Low
13.5%
Company Classification
Sector and industry context.
Sector
Technology
Industry
Semiconductors
Additional Signals
Free Cash Flow
$30596499456.00
Detailed Analysis
Valuation
At $329.17, AVGO trades at 42.04x trailing earnings and 16.94x forward earnings on the $19.4315 next-year consensus, against 17.63x sales, 15.76x book, 30.06x and a 1.95% free-cash-flow yield on a $1.571 trillion market cap. The forward multiple is genuinely undemanding for a business compounding revenue at 85.5% year over year and earnings at 215.3%, and the supplied of 0.3185 is far inside the 1.5x threshold that normally marks attractive growth-adjusted value. The absolute stack remains demanding, however, because 17.63x sales and a 1.95% cash yield are being measured against a 4.986% risk-free rate, and the shares are still 33.5% below the $495.00 52-week high. The sensitivity is precise: a 10% cut to the $19.4315 next-year estimate at a constant 16.94x multiple implies approximately $296, while a de-rating to 15x on the unchanged estimate implies approximately $291 - both distress paths converge roughly 10%-12% below spot and essentially on the $289.96 52-week low. Upside references are far wider: the $529.10 mean target is 60.7% above spot, the $537.50 median is 63.3% above, the $660.00 high is 100.5% above and the $215.88 low is 34.4% below, a high-to-low ratio of 3.06x. No same-date peer or historical valuation series is supplied, so a relative discount or premium to semiconductor peers cannot be substantiated from this bundle. Net: attractive on forward earnings and , expensive on sales, book and current cash yield, with a de-rating that has already surrendered roughly 81% of the 52-week range without yet confirming a floor.
Balance Sheet
Reported debt-to-equity is 59.60%, roughly 0.60x - a moderate leverage profile rather than a stretched one. Broadcom holds $23.98 billion of cash against $59.42 billion of debt, leaving $35.44 billion of net debt equal to about 2.26% of the $1.571 trillion market cap, with cash covering only 0.40x gross debt. Operating cash flow of $40.65 billion covers gross debt 0.68x, and $30.60 billion of free cash flow would retire net debt in roughly 1.16 years if fully applied; free-cash-flow conversion from operating cash flow is a high-quality 75.3%. Current and quick ratios of 2.50 and 2.15 signal comfortable short-term liquidity, and of 44.24% with of 15.37% indicates high-quality capital productivity. Leverage is manageable and well covered by cash generation, but it is real leverage in a 4.986% long-yield environment, and the prior living analysis flagged a customer-compute SPV carrying partial Broadcom guarantees whose current terms are absent from this bundle, so contingent exposure cannot be sized from this input.
Growth
Reported year-over-year revenue growth is 85.5% and earnings growth is 215.3%, and the six supplied quarterly actuals climbed without interruption from $1.58 in the April 2025 quarter to $1.69, $1.95, $2.05, $2.44 and $3.32 in the July 2026 quarter - roughly 96.4% year over year versus the $1.69 July 2025 quarter and 36.1% sequential growth off the $2.44 April 2026 quarter. Supplied coverage splits the business at approximately $59.4 billion from Semiconductor Solutions and $29.7 billion from Infrastructure Software, giving a second, higher-margin, recurring earnings engine alongside custom AI silicon and networking. The critical caveat is that this pace is not a durable run rate and the forward curve is only now stabilizing: next-year of $19.4315 still sits below its 60-day ($19.55167) and 90-day ($19.58228) marks, but it has risen for two consecutive observed snapshots (30-day $19.3807, 7-day $19.39695, current $19.4315, roughly +0.26%), and current-quarter of $3.83018 is likewise above its 30-day ($3.82526) and 7-day ($3.82818) levels. The bundle provides no organic-versus-acquired revenue split and no historical margin series, which limits confidence in how much of the reported acceleration is structural versus acquisition- and cycle-driven.
Business Quality
Gross margin of 75.52%, operating margin of 54.31%, margin of 58.65% and net profit margin of 42.94% place Broadcom at the very top of the semiconductor profitability distribution and justify a premium multiple on quality grounds. of 44.24% and of 15.37% confirm strong capital productivity, while current and quick ratios of 2.50 and 2.15 provide a real liquidity cushion. Institutional ownership of 79.71% and insider ownership of 1.92% describe a professionally held, deep-liquidity $1.57 trillion large cap with roughly $7.49 billion of average 20-day dollar volume - deep liquidity matters because institutional de-risking can be executed quickly, as it was on October 22 when 28.14 million shares traded. Short interest of only 1.16% of float with a 2.01 short ratio indicates bears are not crowded and the decline is long liquidation rather than aggressive shorting. The offsetting quality risk is concentration: the custom-silicon and networking franchise depends on a small number of hyperscaler customers whose capex schedules and internal silicon strategies can shift quickly, and two supplied articles explicitly frame that customer-concentration question as the key vulnerability in Broadcom's pricing power and cash generation.
Capital Allocation
Operating cash flow of $40.65 billion converts to $30.60 billion of free cash flow, about 75.3% conversion - a high-quality cash engine. The dividend yield is 0.81% with a 32.44% payout ratio, leaving substantial retained capacity for debt reduction, buybacks and product investment, and net debt of $35.44 billion equals roughly 1.16 years of free cash flow. The bundle lists 4,773,629,865 shares outstanding against 4,715,677,998 float shares but provides no share-count history or buyback data, so dilution or repurchase accretion cannot be measured from this input. Historically the company has favored acquisitions over organic R&D intensity, which has created value but also built the current $59.42 billion debt load. Capital deployment looks value-creating at the operating level, though the absence of buyback and SPV detail prevents a complete assessment.
Estimate Revisions
The revision picture improved again at the margin even though the levels remain below their 60- and 90-day marks. Current-quarter of $3.83018 is above its 7-day ($3.82818) and 30-day ($3.82526) levels but below its 60-day ($3.87825) and 90-day ($3.86088) marks, with 24 downward versus 9 upward revisions over 30 days. Next-quarter of $4.08779 is above its 7-day ($4.08301) and 30-day ($4.07566) levels but below its 60-day ($4.13699) and 90-day ($4.12974) marks, carrying 21 downgrades against 9 upgrades. Current-year of $11.65924 is the highest in the observed series and has risen steadily from $11.62703 ninety days ago, with the most constructive revision skew in the bundle at 22 up versus 15 down over 30 days. Next-year of $19.4315 remains below its 60-day ($19.55167) and 90-day ($19.58228) marks with 26 downward versus 13 upward revisions over 30 days, but it has now risen for two consecutive readings from $19.3807 thirty days ago through $19.39695 seven days ago - the first clear inflection in the out-year estimate since the deterioration began. The seven-day revision counts are the tell: zero downgrades on all four buckets and one upgrade on both +1q and +1y, so the downgrade wave has stalled and is beginning to reverse. Firm-level actions over the last 90 days remain net positive - Tigress Financial initiated at Buy with a $600 target on October 22, Piper Sandler initiated at Overweight with $460 on September 10, Citigroup maintained Buy and raised to $515, Macquarie upgraded Neutral to Outperform at $490, and DA Davidson maintained Neutral but cut its target to $350 - while the bundle's own upgrade/downgrade counter reports 0/0 despite those five listed actions, so the counter understates activity.